Brenda Gallie
Affiliations: | University of Toronto, Toronto, ON, Canada |
Area:
Molecular Biology, Cell BiologyGoogle:
"Brenda Gallie"Children
Sign in to add trainee| Vivette D. Brown | grad student | 2001 | University of Toronto |
| David P. DiCiommo | grad student | 2002 | University of Toronto |
| Timothy W Corson | grad student | 2002-2007 | (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fabian ID, Abdallah E, et al. (2020) Global Retinoblastoma Presentation and Analysis by National Income Level. Jama Oncology |
| Soliman SE, VandenHooven C, MacKeen L, et al. (2020) Abstract A68: Optical coherence tomography improves subclinical retinoblastoma management Cancer Research. 80 |
| AlAli A, Kletke S, Gallie B, et al. (2018) Retinoblastoma for Pediatric Ophthalmologists. Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.) |
| Racher H, Soliman S, Argiropoulos B, et al. (2016) Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma. Cancer Genetics |
| Dimaras H, Corson TW, Cobrinik D, et al. (2015) Retinoblastoma. Nature Reviews. Disease Primers. 1: 15021 |
| Corson T, Racher H, Argiropoulos B, et al. (2015) MG-127 Residual disease monitoring in a retinoblastoma patient by pcr of a novel deletion breakpoint Journal of Medical Genetics. 52: A10.2-A10 |
| Thériault BL, Basavarajappa HD, Lim H, et al. (2014) Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer. Plos One. 9: e91540 |
| Thériault BL, Dimaras H, Gallie BL, et al. (2014) The genomic landscape of retinoblastoma: a review. Clinical & Experimental Ophthalmology. 42: 33-52 |
| Milea A, George SH, Matevski D, et al. (2014) Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 27: 991-1001 |
| Rushlow DE, Mol BM, Kennett JY, et al. (2013) Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. The Lancet. Oncology. 14: 327-34 |